In the News
Aaron Lipson Discusses Clinical Trial Prediction Market Risks with Law360
October 9, 2026
| Law360
Featured Lawyers:

Aaron Lipson comments on the compliance risks posed by prediction markets tied to clinical drug trials, including potential insider trading and manipulation concerns. 

Third-party coverage: 
'A Moral Hazard': Kalshi Drug Trial Bets Spark Ethical Qualms

Explore King & Spalding
a shelf with boxes on it
Capabilities
Special Matters & Government Investigations
a building with glass walls and a glass door
Capabilities
Securities Enforcement & Regulation